nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—Mitomycin—stomach cancer	0.224	0.454	CbGbCtD
Fesoterodine—ABCB1—Irinotecan—stomach cancer	0.0573	0.116	CbGbCtD
Fesoterodine—ABCB1—Docetaxel—stomach cancer	0.042	0.0853	CbGbCtD
Fesoterodine—CYP3A4—Irinotecan—stomach cancer	0.0344	0.0698	CbGbCtD
Fesoterodine—ABCB1—Doxorubicin—stomach cancer	0.0313	0.0636	CbGbCtD
Fesoterodine—ABCB1—Methotrexate—stomach cancer	0.0303	0.0616	CbGbCtD
Fesoterodine—CYP2D6—Doxorubicin—stomach cancer	0.0295	0.0599	CbGbCtD
Fesoterodine—CYP3A4—Docetaxel—stomach cancer	0.0252	0.0511	CbGbCtD
Fesoterodine—CYP3A4—Doxorubicin—stomach cancer	0.0188	0.0381	CbGbCtD
Fesoterodine—CHRM3—muscle of abdomen—stomach cancer	0.00571	0.404	CbGeAlD
Fesoterodine—CHRM5—epithelium—stomach cancer	0.00122	0.086	CbGeAlD
Fesoterodine—Urinary tract disorder—Capecitabine—stomach cancer	0.000867	0.00268	CcSEcCtD
Fesoterodine—Oedema peripheral—Capecitabine—stomach cancer	0.000865	0.00267	CcSEcCtD
Fesoterodine—Urethral disorder—Capecitabine—stomach cancer	0.00086	0.00266	CcSEcCtD
Fesoterodine—Face oedema—Epirubicin—stomach cancer	0.000853	0.00264	CcSEcCtD
Fesoterodine—Eye disorder—Docetaxel—stomach cancer	0.000847	0.00262	CcSEcCtD
Fesoterodine—Insomnia—Irinotecan—stomach cancer	0.000843	0.00261	CcSEcCtD
Fesoterodine—Cardiac disorder—Docetaxel—stomach cancer	0.000841	0.0026	CcSEcCtD
Fesoterodine—Somnolence—Irinotecan—stomach cancer	0.000828	0.00256	CcSEcCtD
Fesoterodine—Eye disorder—Capecitabine—stomach cancer	0.00082	0.00254	CcSEcCtD
Fesoterodine—Dyspepsia—Irinotecan—stomach cancer	0.00082	0.00254	CcSEcCtD
Fesoterodine—Mediastinal disorder—Docetaxel—stomach cancer	0.000817	0.00253	CcSEcCtD
Fesoterodine—Cardiac disorder—Capecitabine—stomach cancer	0.000814	0.00252	CcSEcCtD
Fesoterodine—Dry skin—Epirubicin—stomach cancer	0.00081	0.00251	CcSEcCtD
Fesoterodine—Abdominal pain upper—Epirubicin—stomach cancer	0.000807	0.0025	CcSEcCtD
Fesoterodine—Insomnia—Fluorouracil—stomach cancer	0.000807	0.0025	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000804	0.00249	CcSEcCtD
Fesoterodine—Fatigue—Irinotecan—stomach cancer	0.000803	0.00248	CcSEcCtD
Fesoterodine—Constipation—Irinotecan—stomach cancer	0.000797	0.00246	CcSEcCtD
Fesoterodine—Mental disorder—Docetaxel—stomach cancer	0.000794	0.00246	CcSEcCtD
Fesoterodine—Somnolence—Fluorouracil—stomach cancer	0.000793	0.00245	CcSEcCtD
Fesoterodine—Mediastinal disorder—Capecitabine—stomach cancer	0.000791	0.00245	CcSEcCtD
Fesoterodine—Face oedema—Doxorubicin—stomach cancer	0.000789	0.00244	CcSEcCtD
Fesoterodine—Dyspepsia—Fluorouracil—stomach cancer	0.000785	0.00243	CcSEcCtD
Fesoterodine—Abdominal discomfort—Methotrexate—stomach cancer	0.000782	0.00242	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000779	0.00241	CcSEcCtD
Fesoterodine—Dysgeusia—Docetaxel—stomach cancer	0.000773	0.00239	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00077	0.00238	CcSEcCtD
Fesoterodine—Mental disorder—Capecitabine—stomach cancer	0.000769	0.00238	CcSEcCtD
Fesoterodine—Feeling abnormal—Irinotecan—stomach cancer	0.000768	0.00237	CcSEcCtD
Fesoterodine—Back pain—Docetaxel—stomach cancer	0.000763	0.00236	CcSEcCtD
Fesoterodine—Dysuria—Methotrexate—stomach cancer	0.000763	0.00236	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000762	0.00236	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000759	0.00235	CcSEcCtD
Fesoterodine—Flatulence—Capecitabine—stomach cancer	0.000753	0.00233	CcSEcCtD
Fesoterodine—Dry skin—Doxorubicin—stomach cancer	0.00075	0.00232	CcSEcCtD
Fesoterodine—Dysgeusia—Capecitabine—stomach cancer	0.000748	0.00231	CcSEcCtD
Fesoterodine—Abdominal pain upper—Doxorubicin—stomach cancer	0.000747	0.00231	CcSEcCtD
Fesoterodine—Angina pectoris—Epirubicin—stomach cancer	0.000744	0.0023	CcSEcCtD
Fesoterodine—Back pain—Capecitabine—stomach cancer	0.000739	0.00229	CcSEcCtD
Fesoterodine—Abdominal pain—Irinotecan—stomach cancer	0.000736	0.00228	CcSEcCtD
Fesoterodine—Feeling abnormal—Fluorouracil—stomach cancer	0.000735	0.00227	CcSEcCtD
Fesoterodine—Infestation—Methotrexate—stomach cancer	0.000728	0.00225	CcSEcCtD
Fesoterodine—Infestation NOS—Methotrexate—stomach cancer	0.000728	0.00225	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000721	0.00223	CcSEcCtD
Fesoterodine—Vision blurred—Capecitabine—stomach cancer	0.00072	0.00223	CcSEcCtD
Fesoterodine—Dysuria—Epirubicin—stomach cancer	0.000714	0.00221	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Epirubicin—stomach cancer	0.00071	0.0022	CcSEcCtD
Fesoterodine—Urticaria—Fluorouracil—stomach cancer	0.000709	0.00219	CcSEcCtD
Fesoterodine—Palpitations—Docetaxel—stomach cancer	0.000697	0.00216	CcSEcCtD
Fesoterodine—Cough—Docetaxel—stomach cancer	0.000689	0.00213	CcSEcCtD
Fesoterodine—Angina pectoris—Doxorubicin—stomach cancer	0.000688	0.00213	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Methotrexate—stomach cancer	0.000688	0.00213	CcSEcCtD
Fesoterodine—Vertigo—Capecitabine—stomach cancer	0.000686	0.00212	CcSEcCtD
Fesoterodine—Hypersensitivity—Irinotecan—stomach cancer	0.000686	0.00212	CcSEcCtD
Fesoterodine—Infestation NOS—Epirubicin—stomach cancer	0.000681	0.00211	CcSEcCtD
Fesoterodine—Infestation—Epirubicin—stomach cancer	0.000681	0.00211	CcSEcCtD
Fesoterodine—Palpitations—Capecitabine—stomach cancer	0.000675	0.00209	CcSEcCtD
Fesoterodine—Chest pain—Docetaxel—stomach cancer	0.000672	0.00208	CcSEcCtD
Fesoterodine—Asthenia—Irinotecan—stomach cancer	0.000668	0.00207	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000667	0.00206	CcSEcCtD
Fesoterodine—Cough—Capecitabine—stomach cancer	0.000667	0.00206	CcSEcCtD
Fesoterodine—Urinary tract infection—Epirubicin—stomach cancer	0.000662	0.00205	CcSEcCtD
Fesoterodine—Dysuria—Doxorubicin—stomach cancer	0.000661	0.00204	CcSEcCtD
Fesoterodine—Hypersensitivity—Fluorouracil—stomach cancer	0.000657	0.00203	CcSEcCtD
Fesoterodine—Dry mouth—Docetaxel—stomach cancer	0.000657	0.00203	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000657	0.00203	CcSEcCtD
Fesoterodine—CHRM3—smooth muscle tissue—stomach cancer	0.000656	0.0463	CbGeAlD
Fesoterodine—Chest pain—Capecitabine—stomach cancer	0.00065	0.00201	CcSEcCtD
Fesoterodine—Confusional state—Docetaxel—stomach cancer	0.000649	0.00201	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000646	0.002	CcSEcCtD
Fesoterodine—Urinary tract disorder—Methotrexate—stomach cancer	0.000645	0.002	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Epirubicin—stomach cancer	0.000644	0.00199	CcSEcCtD
Fesoterodine—Urethral disorder—Methotrexate—stomach cancer	0.00064	0.00198	CcSEcCtD
Fesoterodine—Infection—Docetaxel—stomach cancer	0.00064	0.00198	CcSEcCtD
Fesoterodine—Diarrhoea—Irinotecan—stomach cancer	0.000637	0.00197	CcSEcCtD
Fesoterodine—Dry mouth—Capecitabine—stomach cancer	0.000636	0.00197	CcSEcCtD
Fesoterodine—Nervous system disorder—Docetaxel—stomach cancer	0.000632	0.00195	CcSEcCtD
Fesoterodine—Pruritus—Fluorouracil—stomach cancer	0.000631	0.00195	CcSEcCtD
Fesoterodine—Infestation NOS—Doxorubicin—stomach cancer	0.00063	0.00195	CcSEcCtD
Fesoterodine—Infestation—Doxorubicin—stomach cancer	0.00063	0.00195	CcSEcCtD
Fesoterodine—Confusional state—Capecitabine—stomach cancer	0.000629	0.00194	CcSEcCtD
Fesoterodine—Tachycardia—Docetaxel—stomach cancer	0.000629	0.00194	CcSEcCtD
Fesoterodine—Skin disorder—Docetaxel—stomach cancer	0.000626	0.00193	CcSEcCtD
Fesoterodine—Infection—Capecitabine—stomach cancer	0.000619	0.00192	CcSEcCtD
Fesoterodine—Dizziness—Irinotecan—stomach cancer	0.000616	0.00191	CcSEcCtD
Fesoterodine—Urinary tract infection—Doxorubicin—stomach cancer	0.000613	0.00189	CcSEcCtD
Fesoterodine—Nervous system disorder—Capecitabine—stomach cancer	0.000611	0.00189	CcSEcCtD
Fesoterodine—Eye disorder—Methotrexate—stomach cancer	0.000611	0.00189	CcSEcCtD
Fesoterodine—Diarrhoea—Fluorouracil—stomach cancer	0.00061	0.00189	CcSEcCtD
Fesoterodine—Tachycardia—Capecitabine—stomach cancer	0.000609	0.00188	CcSEcCtD
Fesoterodine—Cardiac disorder—Methotrexate—stomach cancer	0.000606	0.00188	CcSEcCtD
Fesoterodine—Skin disorder—Capecitabine—stomach cancer	0.000606	0.00187	CcSEcCtD
Fesoterodine—Urinary tract disorder—Epirubicin—stomach cancer	0.000604	0.00187	CcSEcCtD
Fesoterodine—Oedema peripheral—Epirubicin—stomach cancer	0.000602	0.00186	CcSEcCtD
Fesoterodine—Urethral disorder—Epirubicin—stomach cancer	0.000599	0.00185	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000596	0.00184	CcSEcCtD
Fesoterodine—Dizziness—Fluorouracil—stomach cancer	0.00059	0.00182	CcSEcCtD
Fesoterodine—Mediastinal disorder—Methotrexate—stomach cancer	0.000589	0.00182	CcSEcCtD
Fesoterodine—Rash—Irinotecan—stomach cancer	0.000587	0.00182	CcSEcCtD
Fesoterodine—Dermatitis—Irinotecan—stomach cancer	0.000587	0.00181	CcSEcCtD
Fesoterodine—Headache—Irinotecan—stomach cancer	0.000584	0.0018	CcSEcCtD
Fesoterodine—Insomnia—Docetaxel—stomach cancer	0.000582	0.0018	CcSEcCtD
Fesoterodine—Somnolence—Docetaxel—stomach cancer	0.000573	0.00177	CcSEcCtD
Fesoterodine—Mental disorder—Methotrexate—stomach cancer	0.000572	0.00177	CcSEcCtD
Fesoterodine—Eye disorder—Epirubicin—stomach cancer	0.000571	0.00177	CcSEcCtD
Fesoterodine—Cardiac disorder—Epirubicin—stomach cancer	0.000567	0.00175	CcSEcCtD
Fesoterodine—Dyspepsia—Docetaxel—stomach cancer	0.000567	0.00175	CcSEcCtD
Fesoterodine—Insomnia—Capecitabine—stomach cancer	0.000564	0.00174	CcSEcCtD
Fesoterodine—Rash—Fluorouracil—stomach cancer	0.000563	0.00174	CcSEcCtD
Fesoterodine—Dermatitis—Fluorouracil—stomach cancer	0.000562	0.00174	CcSEcCtD
Fesoterodine—Headache—Fluorouracil—stomach cancer	0.000559	0.00173	CcSEcCtD
Fesoterodine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000559	0.00173	CcSEcCtD
Fesoterodine—Oedema peripheral—Doxorubicin—stomach cancer	0.000557	0.00172	CcSEcCtD
Fesoterodine—Dysgeusia—Methotrexate—stomach cancer	0.000557	0.00172	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000556	0.00172	CcSEcCtD
Fesoterodine—Fatigue—Docetaxel—stomach cancer	0.000555	0.00172	CcSEcCtD
Fesoterodine—Urethral disorder—Doxorubicin—stomach cancer	0.000555	0.00171	CcSEcCtD
Fesoterodine—Nausea—Irinotecan—stomach cancer	0.000553	0.00171	CcSEcCtD
Fesoterodine—Mediastinal disorder—Epirubicin—stomach cancer	0.000551	0.0017	CcSEcCtD
Fesoterodine—Constipation—Docetaxel—stomach cancer	0.000551	0.0017	CcSEcCtD
Fesoterodine—Back pain—Methotrexate—stomach cancer	0.00055	0.0017	CcSEcCtD
Fesoterodine—Dyspepsia—Capecitabine—stomach cancer	0.000549	0.0017	CcSEcCtD
Fesoterodine—ABCB1—blood vessel—stomach cancer	0.000544	0.0384	CbGeAlD
Fesoterodine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000538	0.00166	CcSEcCtD
Fesoterodine—Fatigue—Capecitabine—stomach cancer	0.000538	0.00166	CcSEcCtD
Fesoterodine—Vision blurred—Methotrexate—stomach cancer	0.000536	0.00166	CcSEcCtD
Fesoterodine—Mental disorder—Epirubicin—stomach cancer	0.000536	0.00166	CcSEcCtD
Fesoterodine—Constipation—Capecitabine—stomach cancer	0.000533	0.00165	CcSEcCtD
Fesoterodine—Feeling abnormal—Docetaxel—stomach cancer	0.000531	0.00164	CcSEcCtD
Fesoterodine—Nausea—Fluorouracil—stomach cancer	0.00053	0.00164	CcSEcCtD
Fesoterodine—Eye disorder—Doxorubicin—stomach cancer	0.000529	0.00163	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000527	0.00163	CcSEcCtD
Fesoterodine—CHRM2—endocrine gland—stomach cancer	0.000525	0.0371	CbGeAlD
Fesoterodine—Cardiac disorder—Doxorubicin—stomach cancer	0.000525	0.00162	CcSEcCtD
Fesoterodine—Flatulence—Epirubicin—stomach cancer	0.000524	0.00162	CcSEcCtD
Fesoterodine—Dysgeusia—Epirubicin—stomach cancer	0.000521	0.00161	CcSEcCtD
Fesoterodine—CHRM3—digestive system—stomach cancer	0.000518	0.0366	CbGeAlD
Fesoterodine—Back pain—Epirubicin—stomach cancer	0.000515	0.00159	CcSEcCtD
Fesoterodine—Feeling abnormal—Capecitabine—stomach cancer	0.000514	0.00159	CcSEcCtD
Fesoterodine—Vertigo—Methotrexate—stomach cancer	0.000511	0.00158	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Capecitabine—stomach cancer	0.00051	0.00158	CcSEcCtD
Fesoterodine—Mediastinal disorder—Doxorubicin—stomach cancer	0.00051	0.00158	CcSEcCtD
Fesoterodine—Abdominal pain—Docetaxel—stomach cancer	0.000509	0.00157	CcSEcCtD
Fesoterodine—Vision blurred—Epirubicin—stomach cancer	0.000502	0.00155	CcSEcCtD
Fesoterodine—Cough—Methotrexate—stomach cancer	0.000496	0.00153	CcSEcCtD
Fesoterodine—Mental disorder—Doxorubicin—stomach cancer	0.000496	0.00153	CcSEcCtD
Fesoterodine—Urticaria—Capecitabine—stomach cancer	0.000495	0.00153	CcSEcCtD
Fesoterodine—Abdominal pain—Capecitabine—stomach cancer	0.000493	0.00152	CcSEcCtD
Fesoterodine—Flatulence—Doxorubicin—stomach cancer	0.000485	0.0015	CcSEcCtD
Fesoterodine—Chest pain—Methotrexate—stomach cancer	0.000484	0.0015	CcSEcCtD
Fesoterodine—Dysgeusia—Doxorubicin—stomach cancer	0.000482	0.00149	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000481	0.00149	CcSEcCtD
Fesoterodine—Vertigo—Epirubicin—stomach cancer	0.000478	0.00148	CcSEcCtD
Fesoterodine—CHRM1—endocrine gland—stomach cancer	0.000478	0.0338	CbGeAlD
Fesoterodine—Back pain—Doxorubicin—stomach cancer	0.000476	0.00147	CcSEcCtD
Fesoterodine—Hypersensitivity—Docetaxel—stomach cancer	0.000474	0.00147	CcSEcCtD
Fesoterodine—Palpitations—Epirubicin—stomach cancer	0.00047	0.00145	CcSEcCtD
Fesoterodine—Confusional state—Methotrexate—stomach cancer	0.000468	0.00145	CcSEcCtD
Fesoterodine—Cough—Epirubicin—stomach cancer	0.000464	0.00144	CcSEcCtD
Fesoterodine—Vision blurred—Doxorubicin—stomach cancer	0.000464	0.00144	CcSEcCtD
Fesoterodine—Asthenia—Docetaxel—stomach cancer	0.000462	0.00143	CcSEcCtD
Fesoterodine—Infection—Methotrexate—stomach cancer	0.000461	0.00143	CcSEcCtD
Fesoterodine—Hypersensitivity—Capecitabine—stomach cancer	0.000459	0.00142	CcSEcCtD
Fesoterodine—Pruritus—Docetaxel—stomach cancer	0.000456	0.00141	CcSEcCtD
Fesoterodine—Nervous system disorder—Methotrexate—stomach cancer	0.000455	0.00141	CcSEcCtD
Fesoterodine—Chest pain—Epirubicin—stomach cancer	0.000453	0.0014	CcSEcCtD
Fesoterodine—Skin disorder—Methotrexate—stomach cancer	0.000451	0.00139	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00045	0.00139	CcSEcCtD
Fesoterodine—Asthenia—Capecitabine—stomach cancer	0.000447	0.00138	CcSEcCtD
Fesoterodine—Dry mouth—Epirubicin—stomach cancer	0.000443	0.00137	CcSEcCtD
Fesoterodine—Vertigo—Doxorubicin—stomach cancer	0.000442	0.00137	CcSEcCtD
Fesoterodine—Pruritus—Capecitabine—stomach cancer	0.000441	0.00136	CcSEcCtD
Fesoterodine—Diarrhoea—Docetaxel—stomach cancer	0.000441	0.00136	CcSEcCtD
Fesoterodine—Confusional state—Epirubicin—stomach cancer	0.000438	0.00135	CcSEcCtD
Fesoterodine—Palpitations—Doxorubicin—stomach cancer	0.000435	0.00135	CcSEcCtD
Fesoterodine—Infection—Epirubicin—stomach cancer	0.000432	0.00133	CcSEcCtD
Fesoterodine—Cough—Doxorubicin—stomach cancer	0.00043	0.00133	CcSEcCtD
Fesoterodine—CHRM3—endocrine gland—stomach cancer	0.000428	0.0302	CbGeAlD
Fesoterodine—Diarrhoea—Capecitabine—stomach cancer	0.000427	0.00132	CcSEcCtD
Fesoterodine—Nervous system disorder—Epirubicin—stomach cancer	0.000426	0.00132	CcSEcCtD
Fesoterodine—Dizziness—Docetaxel—stomach cancer	0.000426	0.00132	CcSEcCtD
Fesoterodine—Tachycardia—Epirubicin—stomach cancer	0.000424	0.00131	CcSEcCtD
Fesoterodine—Skin disorder—Epirubicin—stomach cancer	0.000422	0.0013	CcSEcCtD
Fesoterodine—Insomnia—Methotrexate—stomach cancer	0.00042	0.0013	CcSEcCtD
Fesoterodine—Chest pain—Doxorubicin—stomach cancer	0.000419	0.0013	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000416	0.00129	CcSEcCtD
Fesoterodine—Somnolence—Methotrexate—stomach cancer	0.000413	0.00128	CcSEcCtD
Fesoterodine—Dizziness—Capecitabine—stomach cancer	0.000412	0.00128	CcSEcCtD
Fesoterodine—Dry mouth—Doxorubicin—stomach cancer	0.00041	0.00127	CcSEcCtD
Fesoterodine—CYP3A4—hematopoietic system—stomach cancer	0.000409	0.0289	CbGeAlD
Fesoterodine—Dyspepsia—Methotrexate—stomach cancer	0.000409	0.00126	CcSEcCtD
Fesoterodine—Rash—Docetaxel—stomach cancer	0.000406	0.00126	CcSEcCtD
Fesoterodine—Dermatitis—Docetaxel—stomach cancer	0.000406	0.00125	CcSEcCtD
Fesoterodine—Confusional state—Doxorubicin—stomach cancer	0.000405	0.00125	CcSEcCtD
Fesoterodine—Headache—Docetaxel—stomach cancer	0.000403	0.00125	CcSEcCtD
Fesoterodine—CYP2D6—hematopoietic system—stomach cancer	0.000402	0.0284	CbGeAlD
Fesoterodine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000401	0.00124	CcSEcCtD
Fesoterodine—Fatigue—Methotrexate—stomach cancer	0.0004	0.00124	CcSEcCtD
Fesoterodine—Infection—Doxorubicin—stomach cancer	0.000399	0.00123	CcSEcCtD
Fesoterodine—Nervous system disorder—Doxorubicin—stomach cancer	0.000394	0.00122	CcSEcCtD
Fesoterodine—Rash—Capecitabine—stomach cancer	0.000393	0.00122	CcSEcCtD
Fesoterodine—Insomnia—Epirubicin—stomach cancer	0.000393	0.00121	CcSEcCtD
Fesoterodine—Dermatitis—Capecitabine—stomach cancer	0.000393	0.00121	CcSEcCtD
Fesoterodine—Tachycardia—Doxorubicin—stomach cancer	0.000392	0.00121	CcSEcCtD
Fesoterodine—Headache—Capecitabine—stomach cancer	0.000391	0.00121	CcSEcCtD
Fesoterodine—Skin disorder—Doxorubicin—stomach cancer	0.00039	0.00121	CcSEcCtD
Fesoterodine—Somnolence—Epirubicin—stomach cancer	0.000386	0.00119	CcSEcCtD
Fesoterodine—Nausea—Docetaxel—stomach cancer	0.000383	0.00118	CcSEcCtD
Fesoterodine—Feeling abnormal—Methotrexate—stomach cancer	0.000382	0.00118	CcSEcCtD
Fesoterodine—Dyspepsia—Epirubicin—stomach cancer	0.000382	0.00118	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Methotrexate—stomach cancer	0.00038	0.00117	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000375	0.00116	CcSEcCtD
Fesoterodine—Fatigue—Epirubicin—stomach cancer	0.000374	0.00116	CcSEcCtD
Fesoterodine—Constipation—Epirubicin—stomach cancer	0.000371	0.00115	CcSEcCtD
Fesoterodine—Nausea—Capecitabine—stomach cancer	0.00037	0.00115	CcSEcCtD
Fesoterodine—Urticaria—Methotrexate—stomach cancer	0.000369	0.00114	CcSEcCtD
Fesoterodine—Abdominal pain—Methotrexate—stomach cancer	0.000367	0.00113	CcSEcCtD
Fesoterodine—Insomnia—Doxorubicin—stomach cancer	0.000364	0.00112	CcSEcCtD
Fesoterodine—Feeling abnormal—Epirubicin—stomach cancer	0.000358	0.00111	CcSEcCtD
Fesoterodine—Somnolence—Doxorubicin—stomach cancer	0.000357	0.0011	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000355	0.0011	CcSEcCtD
Fesoterodine—Dyspepsia—Doxorubicin—stomach cancer	0.000354	0.00109	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000347	0.00107	CcSEcCtD
Fesoterodine—Fatigue—Doxorubicin—stomach cancer	0.000347	0.00107	CcSEcCtD
Fesoterodine—Urticaria—Epirubicin—stomach cancer	0.000345	0.00107	CcSEcCtD
Fesoterodine—Constipation—Doxorubicin—stomach cancer	0.000344	0.00106	CcSEcCtD
Fesoterodine—Abdominal pain—Epirubicin—stomach cancer	0.000343	0.00106	CcSEcCtD
Fesoterodine—Hypersensitivity—Methotrexate—stomach cancer	0.000342	0.00106	CcSEcCtD
Fesoterodine—Asthenia—Methotrexate—stomach cancer	0.000333	0.00103	CcSEcCtD
Fesoterodine—Feeling abnormal—Doxorubicin—stomach cancer	0.000331	0.00102	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000329	0.00102	CcSEcCtD
Fesoterodine—Pruritus—Methotrexate—stomach cancer	0.000328	0.00102	CcSEcCtD
Fesoterodine—Hypersensitivity—Epirubicin—stomach cancer	0.00032	0.00099	CcSEcCtD
Fesoterodine—Urticaria—Doxorubicin—stomach cancer	0.000319	0.000987	CcSEcCtD
Fesoterodine—Abdominal pain—Doxorubicin—stomach cancer	0.000318	0.000983	CcSEcCtD
Fesoterodine—Diarrhoea—Methotrexate—stomach cancer	0.000318	0.000982	CcSEcCtD
Fesoterodine—Asthenia—Epirubicin—stomach cancer	0.000312	0.000964	CcSEcCtD
Fesoterodine—Pruritus—Epirubicin—stomach cancer	0.000307	0.00095	CcSEcCtD
Fesoterodine—Dizziness—Methotrexate—stomach cancer	0.000307	0.000949	CcSEcCtD
Fesoterodine—Diarrhoea—Epirubicin—stomach cancer	0.000297	0.000919	CcSEcCtD
Fesoterodine—Hypersensitivity—Doxorubicin—stomach cancer	0.000296	0.000916	CcSEcCtD
Fesoterodine—Rash—Methotrexate—stomach cancer	0.000293	0.000905	CcSEcCtD
Fesoterodine—Dermatitis—Methotrexate—stomach cancer	0.000292	0.000904	CcSEcCtD
Fesoterodine—Headache—Methotrexate—stomach cancer	0.000291	0.000899	CcSEcCtD
Fesoterodine—ABCB1—hematopoietic system—stomach cancer	0.000289	0.0205	CbGeAlD
Fesoterodine—Asthenia—Doxorubicin—stomach cancer	0.000288	0.000892	CcSEcCtD
Fesoterodine—Dizziness—Epirubicin—stomach cancer	0.000287	0.000888	CcSEcCtD
Fesoterodine—CYP3A4—digestive system—stomach cancer	0.000284	0.0201	CbGeAlD
Fesoterodine—Pruritus—Doxorubicin—stomach cancer	0.000284	0.000879	CcSEcCtD
Fesoterodine—CYP2D6—digestive system—stomach cancer	0.00028	0.0198	CbGeAlD
Fesoterodine—Nausea—Methotrexate—stomach cancer	0.000276	0.000853	CcSEcCtD
Fesoterodine—Diarrhoea—Doxorubicin—stomach cancer	0.000275	0.00085	CcSEcCtD
Fesoterodine—Rash—Epirubicin—stomach cancer	0.000274	0.000847	CcSEcCtD
Fesoterodine—Dermatitis—Epirubicin—stomach cancer	0.000274	0.000846	CcSEcCtD
Fesoterodine—Headache—Epirubicin—stomach cancer	0.000272	0.000841	CcSEcCtD
Fesoterodine—Dizziness—Doxorubicin—stomach cancer	0.000266	0.000822	CcSEcCtD
Fesoterodine—ABCB1—epithelium—stomach cancer	0.000265	0.0187	CbGeAlD
Fesoterodine—Nausea—Epirubicin—stomach cancer	0.000258	0.000798	CcSEcCtD
Fesoterodine—Rash—Doxorubicin—stomach cancer	0.000253	0.000784	CcSEcCtD
Fesoterodine—Dermatitis—Doxorubicin—stomach cancer	0.000253	0.000783	CcSEcCtD
Fesoterodine—Headache—Doxorubicin—stomach cancer	0.000252	0.000779	CcSEcCtD
Fesoterodine—Nausea—Doxorubicin—stomach cancer	0.000239	0.000738	CcSEcCtD
Fesoterodine—ABCB1—pancreas—stomach cancer	0.000236	0.0167	CbGeAlD
Fesoterodine—CYP3A4—endocrine gland—stomach cancer	0.000235	0.0166	CbGeAlD
Fesoterodine—CYP2D6—endocrine gland—stomach cancer	0.000231	0.0163	CbGeAlD
Fesoterodine—CYP3A4—liver—stomach cancer	0.000212	0.015	CbGeAlD
Fesoterodine—CYP2D6—liver—stomach cancer	0.000209	0.0147	CbGeAlD
Fesoterodine—ABCB1—lymphoid tissue—stomach cancer	0.000204	0.0144	CbGeAlD
Fesoterodine—ABCB1—digestive system—stomach cancer	0.000201	0.0142	CbGeAlD
Fesoterodine—ABCB1—bone marrow—stomach cancer	0.000186	0.0131	CbGeAlD
Fesoterodine—ABCB1—endocrine gland—stomach cancer	0.000166	0.0118	CbGeAlD
Fesoterodine—ABCB1—liver—stomach cancer	0.00015	0.0106	CbGeAlD
Fesoterodine—ABCB1—lymph node—stomach cancer	0.000115	0.00812	CbGeAlD
Fesoterodine—CHRM2—Signaling by GPCR—RHOA—stomach cancer	2.58e-05	0.000152	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.58e-05	0.000151	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SMAD4—stomach cancer	2.55e-05	0.00015	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SMAD4—stomach cancer	2.54e-05	0.000149	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6R—stomach cancer	2.53e-05	0.000149	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	2.52e-05	0.000148	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SMAD4—stomach cancer	2.52e-05	0.000148	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	2.51e-05	0.000148	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—MAPK3—stomach cancer	2.5e-05	0.000147	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	2.49e-05	0.000146	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—MAPK1—stomach cancer	2.48e-05	0.000146	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—EGFR—stomach cancer	2.48e-05	0.000146	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CD44—stomach cancer	2.44e-05	0.000144	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6R—stomach cancer	2.42e-05	0.000143	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FYN—stomach cancer	2.42e-05	0.000142	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SREBF2—stomach cancer	2.42e-05	0.000142	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FYN—stomach cancer	2.41e-05	0.000142	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CAV1—stomach cancer	2.41e-05	0.000141	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—APOA1—stomach cancer	2.4e-05	0.000141	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FYN—stomach cancer	2.39e-05	0.000141	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—RORA—stomach cancer	2.39e-05	0.000141	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—MAPK1—stomach cancer	2.38e-05	0.00014	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EGFR—stomach cancer	2.38e-05	0.00014	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—PIK3CA—stomach cancer	2.37e-05	0.00014	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SERPINE1—stomach cancer	2.37e-05	0.000139	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—KRAS—stomach cancer	2.35e-05	0.000138	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CD44—stomach cancer	2.3e-05	0.000135	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	2.29e-05	0.000135	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RHOA—stomach cancer	2.29e-05	0.000134	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	2.28e-05	0.000134	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—PIK3CA—stomach cancer	2.27e-05	0.000134	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGFR2—stomach cancer	2.27e-05	0.000134	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SERPINE1—stomach cancer	2.27e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGFR2—stomach cancer	2.27e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOS3—stomach cancer	2.26e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	2.26e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—KRAS—stomach cancer	2.25e-05	0.000132	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGFR2—stomach cancer	2.24e-05	0.000132	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDOB—stomach cancer	2.24e-05	0.000132	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RHOA—stomach cancer	2.19e-05	0.000129	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOS3—stomach cancer	2.17e-05	0.000127	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—PIK3CA—stomach cancer	2.16e-05	0.000127	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ERBB2—stomach cancer	2.12e-05	0.000124	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARG—stomach cancer	2.11e-05	0.000124	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALOX5—stomach cancer	2.08e-05	0.000122	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS2—stomach cancer	2.08e-05	0.000122	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.08e-05	0.000122	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS2—stomach cancer	2.07e-05	0.000122	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PIK3CA—stomach cancer	2.06e-05	0.000121	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS2—stomach cancer	2.05e-05	0.000121	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—DPYD—stomach cancer	2.05e-05	0.00012	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTP1—stomach cancer	2.04e-05	0.00012	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ERBB2—stomach cancer	2.03e-05	0.000119	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CAV1—stomach cancer	2.02e-05	0.000119	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOA1—stomach cancer	2.01e-05	0.000118	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CAV1—stomach cancer	2.01e-05	0.000118	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—stomach cancer	2.01e-05	0.000118	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCL8—stomach cancer	2.01e-05	0.000118	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOA1—stomach cancer	2.01e-05	0.000118	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HRAS—stomach cancer	1.99e-05	0.000117	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CAV1—stomach cancer	1.99e-05	0.000117	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOA1—stomach cancer	1.99e-05	0.000117	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CDKN1B—stomach cancer	1.96e-05	0.000115	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.96e-05	0.000115	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCL8—stomach cancer	1.92e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PRKCB—stomach cancer	1.92e-05	0.000113	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTP1—stomach cancer	1.92e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PRKCB—stomach cancer	1.91e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6ST—stomach cancer	1.91e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HRAS—stomach cancer	1.91e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—stomach cancer	1.91e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6ST—stomach cancer	1.91e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALB—stomach cancer	1.9e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PRKCB—stomach cancer	1.9e-05	0.000111	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TYMS—stomach cancer	1.89e-05	0.000111	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—stomach cancer	1.89e-05	0.000111	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6ST—stomach cancer	1.89e-05	0.000111	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CDKN1B—stomach cancer	1.88e-05	0.00011	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTM1—stomach cancer	1.87e-05	0.00011	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCND1—stomach cancer	1.87e-05	0.00011	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—JUN—stomach cancer	1.87e-05	0.00011	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APC—stomach cancer	1.84e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APC—stomach cancer	1.83e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—stomach cancer	1.83e-05	0.000107	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—stomach cancer	1.82e-05	0.000107	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—stomach cancer	1.82e-05	0.000107	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APC—stomach cancer	1.81e-05	0.000107	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTT1—stomach cancer	1.81e-05	0.000107	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CDKN1A—stomach cancer	1.81e-05	0.000106	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCND1—stomach cancer	1.79e-05	0.000105	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.79e-05	0.000105	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—JUN—stomach cancer	1.79e-05	0.000105	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TYMS—stomach cancer	1.78e-05	0.000105	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK8—stomach cancer	1.77e-05	0.000104	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTM1—stomach cancer	1.76e-05	0.000104	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ERCC2—stomach cancer	1.76e-05	0.000104	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	1.76e-05	0.000104	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	1.75e-05	0.000103	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.74e-05	0.000102	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—stomach cancer	1.74e-05	0.000102	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	1.74e-05	0.000102	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CDKN1A—stomach cancer	1.73e-05	0.000102	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6R—stomach cancer	1.71e-05	0.0001	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6R—stomach cancer	1.7e-05	0.0001	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ENO1—stomach cancer	1.7e-05	9.98e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK8—stomach cancer	1.69e-05	9.94e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6R—stomach cancer	1.68e-05	9.91e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	1.67e-05	9.85e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EGFR—stomach cancer	1.67e-05	9.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	1.67e-05	9.82e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EGFR—stomach cancer	1.67e-05	9.82e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—stomach cancer	1.66e-05	9.78e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ERCC2—stomach cancer	1.66e-05	9.76e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—stomach cancer	1.65e-05	9.73e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	1.65e-05	9.72e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EGFR—stomach cancer	1.65e-05	9.72e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—stomach cancer	1.63e-05	9.59e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—STAT3—stomach cancer	1.61e-05	9.49e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	1.6e-05	9.41e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	1.6e-05	9.4e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	1.6e-05	9.38e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	1.59e-05	9.37e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—KRAS—stomach cancer	1.58e-05	9.3e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	1.58e-05	9.29e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	1.58e-05	9.28e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—KRAS—stomach cancer	1.58e-05	9.27e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—KRAS—stomach cancer	1.56e-05	9.18e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—stomach cancer	1.56e-05	9.18e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—stomach cancer	1.56e-05	9.17e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—STAT3—stomach cancer	1.55e-05	9.09e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK3—stomach cancer	1.54e-05	9.07e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RHOA—stomach cancer	1.54e-05	9.07e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RHOA—stomach cancer	1.54e-05	9.04e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CAV1—stomach cancer	1.53e-05	8.98e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—stomach cancer	1.53e-05	8.97e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOA1—stomach cancer	1.52e-05	8.96e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RHOA—stomach cancer	1.52e-05	8.95e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—stomach cancer	1.52e-05	8.94e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—stomach cancer	1.51e-05	8.86e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CD44—stomach cancer	1.51e-05	8.85e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MYC—stomach cancer	1.5e-05	8.82e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK3—stomach cancer	1.48e-05	8.69e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK1—stomach cancer	1.47e-05	8.63e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EGFR—stomach cancer	1.47e-05	8.63e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	1.45e-05	8.55e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	1.45e-05	8.52e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CAV1—stomach cancer	1.44e-05	8.46e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MYC—stomach cancer	1.44e-05	8.45e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOA1—stomach cancer	1.44e-05	8.44e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	1.43e-05	8.44e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ERBB2—stomach cancer	1.43e-05	8.39e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ERBB2—stomach cancer	1.42e-05	8.37e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ERBB2—stomach cancer	1.41e-05	8.29e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK1—stomach cancer	1.41e-05	8.26e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EGFR—stomach cancer	1.4e-05	8.26e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KRAS—stomach cancer	1.39e-05	8.15e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL8—stomach cancer	1.35e-05	7.96e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL8—stomach cancer	1.35e-05	7.93e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HRAS—stomach cancer	1.34e-05	7.91e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARG—stomach cancer	1.34e-05	7.89e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HRAS—stomach cancer	1.34e-05	7.88e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL8—stomach cancer	1.34e-05	7.86e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HRAS—stomach cancer	1.33e-05	7.81e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KRAS—stomach cancer	1.33e-05	7.81e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	1.32e-05	7.77e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	1.32e-05	7.75e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	1.3e-05	7.67e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—stomach cancer	1.29e-05	7.57e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—stomach cancer	1.28e-05	7.54e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.28e-05	7.53e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	1.27e-05	7.49e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—stomach cancer	1.27e-05	7.47e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARG—stomach cancer	1.26e-05	7.44e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCND1—stomach cancer	1.26e-05	7.42e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—JUN—stomach cancer	1.26e-05	7.4e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCND1—stomach cancer	1.26e-05	7.39e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTP1—stomach cancer	1.26e-05	7.38e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—JUN—stomach cancer	1.25e-05	7.38e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCND1—stomach cancer	1.24e-05	7.32e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—JUN—stomach cancer	1.24e-05	7.3e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—stomach cancer	1.24e-05	7.28e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—stomach cancer	1.23e-05	7.24e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—stomach cancer	1.22e-05	7.2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—stomach cancer	1.22e-05	7.18e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	1.22e-05	7.17e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	1.22e-05	7.17e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	1.22e-05	7.15e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—stomach cancer	1.21e-05	7.11e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALB—stomach cancer	1.21e-05	7.1e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	1.2e-05	7.08e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	1.19e-05	7e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK8—stomach cancer	1.19e-05	6.98e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—stomach cancer	1.18e-05	6.94e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HRAS—stomach cancer	1.18e-05	6.93e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	1.18e-05	6.91e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TYMS—stomach cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—stomach cancer	1.15e-05	6.79e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTM1—stomach cancer	1.15e-05	6.78e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALB—stomach cancer	1.14e-05	6.69e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HRAS—stomach cancer	1.13e-05	6.63e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—stomach cancer	1.13e-05	6.63e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	1.1e-05	6.46e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—stomach cancer	1.1e-05	6.44e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—STAT3—stomach cancer	1.09e-05	6.4e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—stomach cancer	1.09e-05	6.4e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—STAT3—stomach cancer	1.08e-05	6.38e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ERCC2—stomach cancer	1.08e-05	6.38e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—stomach cancer	1.08e-05	6.35e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—STAT3—stomach cancer	1.07e-05	6.32e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—stomach cancer	1.06e-05	6.21e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	1.04e-05	6.12e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK3—stomach cancer	1.04e-05	6.1e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	1.03e-05	6.04e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CA—stomach cancer	1.02e-05	6.02e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—stomach cancer	1.02e-05	6e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MYC—stomach cancer	1.01e-05	5.95e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MYC—stomach cancer	1.01e-05	5.93e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MYC—stomach cancer	9.98e-06	5.87e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—stomach cancer	9.95e-06	5.85e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	9.89e-06	5.82e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EGFR—stomach cancer	9.89e-06	5.82e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK1—stomach cancer	9.86e-06	5.8e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EGFR—stomach cancer	9.86e-06	5.8e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	9.77e-06	5.74e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EGFR—stomach cancer	9.76e-06	5.74e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CAV1—stomach cancer	9.4e-06	5.53e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOA1—stomach cancer	9.38e-06	5.52e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KRAS—stomach cancer	9.34e-06	5.5e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KRAS—stomach cancer	9.32e-06	5.48e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KRAS—stomach cancer	9.22e-06	5.43e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	8.59e-06	5.05e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	8.56e-06	5.03e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	8.47e-06	4.98e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—stomach cancer	8.31e-06	4.88e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—stomach cancer	8.28e-06	4.87e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARG—stomach cancer	8.27e-06	4.86e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—stomach cancer	8.2e-06	4.82e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HRAS—stomach cancer	7.94e-06	4.67e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HRAS—stomach cancer	7.92e-06	4.66e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HRAS—stomach cancer	7.84e-06	4.61e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—stomach cancer	7.6e-06	4.47e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—stomach cancer	7.58e-06	4.46e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—stomach cancer	7.5e-06	4.41e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALB—stomach cancer	7.43e-06	4.37e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—stomach cancer	7.11e-06	4.18e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—stomach cancer	6.5e-06	3.82e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CA—stomach cancer	6.49e-06	3.82e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CA—stomach cancer	6.12e-06	3.6e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CA—stomach cancer	4e-06	2.35e-05	CbGpPWpGaD
